Clinical Trial Update: Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial assessing metformin to counteract deleterious metabolic effects of glucocorticoids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid Effect

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Eleonora Seelig | Conditions: Glucocorticoid Effect | Phase 4 | Status: COMPLETED